Benign liver diseases are a cause of increased serum levels of CEA. We studied the behavior of CEA in 86 patients with liver cirrhosis who underwent extensive clinical and laboratory evaluation. We found abnormal CEA levels in 38.4% of the patients (28.6% Child's grade A, 40.6% Child's B, and 42.4% Child's C) with a mean of 4.75 ng/ml. Significant differences were found between patients and controls. There was a trend towards higher levels of CEA in more severe cirrhosis according to Child's classification, although this was not significant. We found significant correlations between CEA and some liver tests, including glycocholic acid (r = 0.264., p = 0.012), a marker of severity in liver diseases. The increase of CEA in these patients is probably due to alterations in its metabolic processing caused by hepatocellular dysfunction. Moderate elevations of serum CEA can be expected in cirrhotic patients independently of malignancy.
GoldP., FreedmanS.O.Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques.J Exp Med1965; 121: 439–62.
2.
HammarstromS., EngvallE., JohanssonB.G., SvenssonS., SundbladG., GoldsteinI.J.Nature of the tumor-associated determinant(s) of carcinoembryonic antigen.Proc Natl Acad Sci USA1975; 72: 1528–32.
3.
HammarstromS.Chemistry and immunology of CEA, CA 19-9 and CA-50. In: HolmgrenJ., ed. Tumor marker antigens.Lund: Studentlitteratur, 1985; 34–51.
4.
Urrutia de DiegoA.Antigeno carcinoembrionario (CEA). Determinación de sus niveles séricos mediante anticuerpos monoclonales. Estudio comparativo conel método convencional. Barcelona: Universidad Autónoma de Barcelona, 1988. Doctoral Thesis.
5.
HansenH.J., SnyderJ.J., MillerE.Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.Hum Pathol1974; 5: 139–47.
6.
TorosianM.H.The clinical usefulness and limitations of tumor markers.Surg Gynecol Obstet1988; 166: 567–79.
7.
GoldenbergDM modCarcinoembryonic antigen: its role as a marker in the management of cancer.Ann Intern Med1981; 94: 407–9.
LoewensteinM.S., ZamcheckN.Carcinoembryonic antigen and the liver.Gastroenterology1977; 72: 161–6.
10.
PomboL., RuibalA., SorianoA., DuqueJ.J., FombellidaJ.C.Comportamiento del CEA MARIA sérico en pacientes portadores de patologías no tumorales. Comparación con un radioinmunoanálisis policlonal.Rev Clin Esp1988; 183: 383–4.
11.
BullenA.W., LosowskyM.S., CarterS., PatelS., NevilleA.M., PathM.R.C.Diagnostic usefulness of plasma carcinoembryonic antigen levels in acute and chronic liver disease.Gastroenterology1977; 73: 673–8.
12.
GeorgeP.K., LoewensteinM.S., O'BrienM.J., BronsteinB., KoffR.S., ZamcheckN.Circulating CEA levels in patients with fulminant hepatitis.Dig Dis Sci1982; 27: 139–42.
SakamotoK., HagaY., YoshimuraR., EgamiH., YokoyamaY., AkagiM.Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.Gut1987; 28: 323–9.
15.
ChildC.G., TurcotteJ.G.Surgery in portal hypertension. In: ChildC.G., ed. The liver and portal hypertension.Philadelphia: WB Saunders, 1964; 50–72.
16.
PughR.N.H., Murray-LyonI.M., DawsonJ.L., PietroniM.C., WilliamsR.Transection of the oesophagus for bleeding oesophageal varices.Br J Surg1973; 60: 646–9.
17.
ChristensenE., SchlichtingP., FauerholdtL.Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.Hepatology1984; 4: 430–5.
18.
SoxHCJr.Probability theory in the use of diagnostic tests. An introduction to critical study of the literature.Ann Intern Med1986; 104: 60–6.
KhooS.K., MackayI.R.Carcinoembryonic antigen in serum in diseases of the liver and pancreas.J Clin Pathol1973; 26: 470–5.
22.
PönkäA., ForslundT.Cardiac failure, hepatic congestion and increased level of serum carcinoembryonic antigen.Postgrad Med J1984; 60: 56–7.
23.
SavrinR.A., MartinEWJr.The relationship of the possible hepatic toxicity of chemotherapeutic drugs and carcinoembryonic antigen elevation.Cancer1981; 47: 481–5.
MooreT.L., KupchikH.Z., MarconN., ZamcheckN.Carcinoembryonic antigen assay in cancer of the colon and pancreas and other digestive tract disorders.Am J Dig Dis1971; 16: 1–7.
AdachiY., NannoT., ItohT.Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.Gastroenterol Jpn1988; 23: 401–7.
30.
SvenbergT., HammarstromS., HedinA.Purification and properties of biliary glycoprotein I (BGP I). Immunochemical relationship to carcinoembryonic antigen.Mol Immunol1979; 16: 245–52.
31.
SvenbergT., WahrenB., HammarstromS.Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease.Clin Exp Immunol1979; 36: 317–25.
32.
SvenbergT., HammarstromS., AnderssonG., JohanssonC., SamuelsonK., WahrenB.Serum levels of biliary glycoprotein I, a determinant of cholestasis, of similar use as gamma-glutamyltranspeptidase.Scand J Gastroenterol1981; 16: 817–24.
